[Government modernisation of the 'old' pharmaceutical business (2008-2011). Report 2. Pharmaceutical future and biosafety].

This series of articles is devoted to an analysis of the drug safety policy of the Russian Federation. The second communication focuses on the history of strategy development and choice of tactics for pharmaceutical industry modernisation, the spectrum of interests of the concept-makers and the contradictions between the approaches. Based on journal publications and oral interviews, the authors traced the process of creating a regulatory agreement between political authorities and professional groups on power sharing and management delegation after the recognition of the pharmaceutical market as an object of state security.